STOCK TITAN

Nephros Inc Stock Price, News & Analysis

NEPH Nasdaq

Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.

Nephros, Inc. (Nasdaq: NEPH) is a water technology company focused on filtration products, services, and water-quality education for medical, healthcare, commercial, and industrial markets. The NEPH news feed highlights how the company’s filtration solutions and educational initiatives are applied in practice, as well as how its financial performance evolves over time.

News about Nephros often includes quarterly and year-to-date financial results, where the company reports net revenue, net income or loss, gross margin, and adjusted EBITDA. These updates frequently discuss programmatic revenue tied to recurring filter use, emergency response sales related to compromised water events, and trends in service revenue. Investors can use these releases to understand how Nephros’ programmatic business and active customer sites are developing across infection control, dialysis water, and commercial segments.

The NEPH news stream also covers product launches and technology developments. Examples include new filtration products designed to support compliance with water quality standards and to extend Nephros’ technology into additional medical, commercial, and industrial applications. These announcements explain how new offerings fit within the company’s portfolio and which types of facilities or industries they are intended to serve.

Another recurring theme in Nephros news is water safety education. The company reports on webinars, speaking engagements, and the activities of the Nephros Water Institute, which provides regulatory and risk-based educational programming for professionals responsible for water systems. Together, these financial, product, and educational updates give a rounded view of Nephros’ operations and strategic focus. Users interested in NEPH can review this page regularly for the latest company-issued press releases and related disclosures.

Rhea-AI Summary

Nephros, Inc. (NASDAQ: NEPH), a leading water technology company, announced its participation in the Access to Giving Virtual Investor Conference from July 13-15, 2021. CEO Andy Astor will present on July 13th at 2:30 PM ET, with a replay available post-event. The conference will feature over 50 companies focusing on investor education and financial literacy. Nephros aims to advance water safety through innovative solutions. For more details, visit their official site or register for the conference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
none
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) reported an anticipated net revenue of approximately $2.2 million for Q2 2021, marking over a 40% year-over-year increase. Year-to-date revenue exceeded $5 million, reflecting a 20% increase compared to the same period in 2020 and 2019. The company also submitted its HDF Assist Module for FDA 510(k) clearance and noted growing revenue in its Pathogen Detection Systems business segment. Nephros ended Q2 with around $8.3 million in cash, positioning itself well for the upcoming months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.82%
Tags
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) reported its highest first-quarter revenue of $2.7 million, an increase of 8% compared to the same period last year. The net loss improved by 55% to $0.5 million, while adjusted EBITDA showed a 13% improvement, totaling ($0.7 million). The company attributes this growth to increased customer acquisition and recurring revenue, as healthcare facilities shift focus from COVID-19 to water management. Nephros had cash and equivalents of $8.2 million as of March 31, 2021, indicating a solid financial position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
none
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) announced it will release its first quarter financial results on May 6, 2021, after market close. A conference call is scheduled for the same day at 4:30 PM ET, allowing investors to engage with company executives. Participants can join by calling domestic number 1-844-808-7106 or international number 1-412-317-5285. A replay of the call will be available until May 13, 2021. Nephros specializes in water purification and pathogen detection, focusing on point-of-use water safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
conferences earnings
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) has reported a preliminary net revenue of $2.7 million for Q1 2021, marking a 17% increase from the previous quarter and an 8% rise compared to the same period in 2020. This achievement signifies the highest first-quarter revenue in the company's history and the third-highest quarterly revenue overall. The company ended the quarter with approximately $8.1 million in cash. Results are attributed to strong performance across filtration markets despite the pandemic, with expectations for further growth as vaccination progresses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.63%
Tags
-
Rhea-AI Summary

Nephros, a water technology company specializing in filtration and pathogen detection, announced that CEO Andy Astor will present at the Q1 Virtual Investor Summit from March 23-25, 2021. Nephros's presentation is scheduled for March 23 at 2:30 p.m. ET. Interested participants can register for the event and request one-on-one meetings via the conference's website. Nephros is dedicated to advancing water safety in medical and commercial markets by providing innovative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
conferences
Rhea-AI Summary

Nephros, a water technology leader, announced that CEO Andy Astor will present at the Inaugural Emerging Growth Virtual Conference on March 17-18, 2021. The event will showcase discussions with C-suite executives and feature insights into Nephros' advancements in water safety, including pathogen detection and purification technologies. The conference aims to connect thousands of issuers with investors through presentations and live Q&A sessions. For more details, visit www.nephros.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
conferences
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq:NEPH) reported fourth-quarter 2020 net revenue of $2.3 million, a 26% decline from the previous year's $3.2 million. The full-year revenue dropped 17%, totaling $8.6 million compared to $10.3 million in 2019. The net loss for Q4 was approximately ($759,000), marking a significant increase from a net income of $234,000 in 2019. Adjusted EBITDA shows a loss of ($466,000) for Q4, in contrast to a profit of $374,000 a year earlier. Despite challenges due to COVID-19, the company's CEO expressed optimism for a return to growth in the latter half of 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
-
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH), a water technology leader, will release its fourth quarter and full year 2020 financial results on March 1, 2021, after market close. A conference call is scheduled for the same day at 4:30 PM ET, where management will discuss the financial results and business outlook. Call-in details include a participant dial-in number and a replay option available until March 8, 2021. Nephros focuses on advancing water safety in medical and commercial sectors through innovative filtration and pathogen detection solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.29%
Tags
conferences earnings
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) has appointed Wes Lobo as Chief Marketing Officer, effective immediately. Reporting to CEO Andy Astor, Lobo will lead strategic growth through innovative marketing solutions. With over 20 years of experience in the water business, including roles at Watts Water Technologies and Xylem, he aims to enhance customer connections and expand market reach. Nephros previously grew revenues by over 50% annually before the pandemic and seeks to regain this momentum. Lobo's expertise is anticipated to accelerate the company's growth trajectory.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
management

FAQ

What is the current stock price of Nephros (NEPH)?

The current stock price of Nephros (NEPH) is $2.91 as of March 20, 2026.

What is the market cap of Nephros (NEPH)?

The market cap of Nephros (NEPH) is approximately 31.4M.

NEPH Rankings

NEPH Stock Data

31.40M
9.43M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SOUTH ORANGE

NEPH RSS Feed